Keywords: named, partner, zeltia, cancer, drug, after, weeks

J&J named as partner for Zeltia cancer drug

Article | 10 August 2001

Print This

After weeks of speculation (Marketletters July 23 and August 6), it hasbeen confirmed that Johnson & Johnson has licensed rights to Zeltia of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in